Insulin Mixtard HM 30 / 70 Penfill Drug Information [ Novo Nordisk ]
Table of content
Insulin Mixtard HM 30 / 70 Penfill category:
Active ingredients:
Insulin Mixtard HM 30 / 70 Penfill companies and manufacturers:
General Information
Insulin Mixtard HM 30 / 70 Penfill forms, composition and dosages:
- Injectable; Injection; Insulin Injection Human, monocomponent; Insulin Isophane Injection Human monocomponent 100 IU / ml
Indications, usages and classification codes:
- A10AD01 - Insulin Human
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- Insulina Mixtard HM 30 Novo Nordisk
- Mixtard 10 HM Novo Nordisk
- Mixtard 20 HM Novo Nordisk; JDH Pharmaceutical
- Mixtard 30 HM Novo Nordisk; JDH Pharmaceutical
- Mixtard 30 HM Penfill Novo Nordisk; JDH Pharmaceutical
- Mixtard 40 HM Novo Nordisk
- Mixtard 50 HM Novo Nordisk; JDH Pharmaceutical
- Mixtard HM 10 Novo Nordisk
- Mixtard HM 10 / 90 Novo Nordisk
- Mixtard HM 20 Novo Nordisk
- Mixtard HM 20 / 80 Novo Nordisk; Pentafarma
- Mixtard HM 30 Novo Nordisk
- Mixtard HM 30 / 70 Novo Nordisk; Pentafarma
- Mixtard HM 40 Novo Nordisk
- Mixtard HM 40 / 60 Novo Nordisk
- Mixtard HM 50 Novo Nordisk
- Mixtard HM 50 / 50 Novo Nordisk
- Mixtard 20 HM Novo Nordisk; JDH Pharmaceutical
- Mixtard 30 HM Novo Nordisk; Agencia Lei Va Hong; DKSH; JDH Pharmaceutical; Metro Drug Distribution
- Mixtard 30 HM Penfill Novo Nordisk; Agencia Lei Va Hong; DKSH; JDH Pharmaceutical
- Actrafan HM Novo Nordisk
- Actrap MC Novo Nordisk
- Actraphane 10 Novo Nordisk
- Actraphane 20 Novo Nordisk
- Actraphane 30 Novo Nordisk
- Actraphane 40 Novo Nordisk
- Actraphane 50 Novo Nordisk
- Actraphane HM Novo Nordisk
- Actraphane Human Novo Nordisk
- Actraphane MC Novo Nordisk
- Actrapid Novo Nordisk; Abbott; Pentafarma
- Actrapid HM Novo Nordisk
- Actrapid HM Penfill Novo Nordisk
- Actrapid Human Abbott Laboratories
- Actrapid MC Novo Nordisk
- Actrapid Pork Novo Nordisk
- Anilusin Cryopharma Pizzard y Salud
- Apidra Sanofi-Aventis
- Apidra OptiSet Sanofi-Aventis
- Apidra Solostar Sanofi-Aventis